MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868905. A total of 3 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,662,772 | -38.4% | 374,300 | -2.6% | 0.18% | -35.4% |
| Q2 2023 | $88,750,200 | +354.0% | 384,200 | +376.1% | 0.28% | +301.4% |
| Q1 2023 | $19,550,382 | -57.7% | 80,700 | -49.3% | 0.07% | -33.6% |
| Q4 2022 | $46,207,800 | +59140.8% | 159,200 | +13166.7% | 0.11% | – |
| Q3 2022 | $78,000 | +116.7% | 1,200 | +140.0% | 0.00% | – |
| Q2 2022 | $36,000 | -96.2% | 500 | -94.8% | 0.00% | -100.0% |
| Q1 2022 | $952,000 | -23.6% | 9,700 | -34.0% | 0.00% | 0.0% |
| Q4 2021 | $1,246,000 | +816.2% | 14,700 | +764.7% | 0.00% | – |
| Q3 2021 | $136,000 | +248.7% | 1,700 | +325.0% | 0.00% | – |
| Q2 2021 | $39,000 | -79.1% | 400 | -75.0% | 0.00% | – |
| Q1 2021 | $187,000 | -49.0% | 1,600 | -51.5% | 0.00% | -100.0% |
| Q4 2020 | $367,000 | +138.3% | 3,300 | +153.8% | 0.00% | – |
| Q3 2020 | $154,000 | +13.2% | 1,300 | +8.3% | 0.00% | -100.0% |
| Q2 2020 | $136,000 | -95.3% | 1,200 | -94.8% | 0.00% | -96.9% |
| Q1 2019 | $2,881,000 | -15.1% | 23,000 | -23.6% | 0.03% | +10.3% |
| Q4 2018 | $3,393,000 | +692.8% | 30,100 | +1405.0% | 0.03% | +866.7% |
| Q3 2018 | $428,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 135 | $1,500,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,300 | $367,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |